JARDIANCE PATENTS FACING OPPOSITIONS
JARDIANCE facing oppositions at the European Patent Office (EPO)
| Patent Number | Title | Applicants | Legal Status | Legal Status Date | Oppositions | Activity Alert |
|---|---|---|---|---|---|---|
| EP2981271B1 | Therapeutic uses of empagliflozin | Opposition rejected | Mar 20, 2024 |
KRKA, NOVO MESTO
ALFRED E. TIEFENBACHER
EGIS
TEVA PHARMACEUTICAL
STADA-ARZNEIMITTEL
GENERICS
ZAKLADY FARMACEUTYCZNE POLPHARMA
GILLARD, RICHARD EDWARD
| ||
| EP2981255B1 | Therapeutic uses of empagliflozin | Granted and Under Opposition | Aug 12, 2022 |
TEVA PHARMACEUTICAL INDUSTRIES
ZAKLADY FARMACEUTYCZNE POLPHARMA
SANDOZ
ZENTIVA
STADA ARZNEIMITTEL
SANOVEL IIAC
ADALVO
AERA
HGF
GENERICS
| ||
| EP2986304B1 | Pharmaceutical composition, methods for treating and uses thereof | Granted and Under Opposition | Dec 10, 2021 |
ZAKLADY FARMACEUTYCZNE POLPHARMA
SANDOZ
KRAUS & WEISERT
STADA ARZNEIMITTEL
| ||
| EP2187879B1 | Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative | Granted and Under Opposition | Dec 09, 2019 |
GENERICS
STADA
HEXAL
ZAKLADY FARMACEUTYCZNE POLPHARMA
|